Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RICHARD JACKSON

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1508081993
CMS profile
340784
Location
BOCA RATON, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$598,886.86

656 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 6 of 14; records 251–300 of 656 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RICHARD JACKSON

NPI 1508081993 · CMS profile ID 340784

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

BOCA RATON, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 6 of 14; records 251–300 of 656 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1508081993?year=2023&recipient=provider&page=6#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RICHARD JACKSON, NPI 1508081993, CMS profile ID 340784. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 14; records 251–300 of 656 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1508081993?year=2023&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). RICHARD JACKSON, NPI 1508081993, CMS profile ID 340784. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 6 of 14; records 251–300 of 656 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1508081993?year=2023&recipient=provider&page=6#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
RICHARD JACKSON, NPI 1508081993, CMS profile ID 340784, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 6 of 14; records 251–300 of 656 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1508081993?year=2023&recipient=provider&page=6#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

656 matching records · $598,886.86 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 656 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 251–300 of 656.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Supernus Pharmaceuticals, Inc. $4,750.0008/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266279 CMS
Supernus Pharmaceuticals, Inc. $348.9008/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266283 CMS
Supernus Pharmaceuticals, Inc. $297.8608/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266287 CMS
Supernus Pharmaceuticals, Inc. $16.7108/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266291 CMS
Supernus Pharmaceuticals, Inc. $2,750.0008/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266295 CMS
Supernus Pharmaceuticals, Inc. $336.7008/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266299 CMS
Supernus Pharmaceuticals, Inc. $64.5308/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266303 CMS
Supernus Pharmaceuticals, Inc. $125.5208/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266307 CMS
Teva Pharmaceuticals USA, Inc. $118.6208/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056653643 CMS
Teva Pharmaceuticals USA, Inc. $2,500.0008/03/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056654035 CMS
Teva Pharmaceuticals USA, Inc. $61.9608/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056654043 CMS
Teva Pharmaceuticals USA, Inc. $32.2208/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056654139 CMS
Teva Pharmaceuticals USA, Inc. $1,427.4508/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056654143 CMS
Teva Pharmaceuticals USA, Inc. $1,436.7908/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056654147 CMS
Teva Pharmaceuticals USA, Inc. $2,323.8408/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056654151 CMS
Teva Pharmaceuticals USA, Inc. $2,500.0008/03/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056654289 CMS
Teva Pharmaceuticals USA, Inc. $125.0008/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056653605 CMS
Teva Pharmaceuticals USA, Inc. $66.5408/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056654039 CMS
Teva Pharmaceuticals USA, Inc. $5,313.0008/02/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056654047 CMS
Supernus Pharmaceuticals, Inc. $40.0007/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266263 CMS
Supernus Pharmaceuticals, Inc. $50.0007/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266267 CMS
Supernus Pharmaceuticals, Inc. $44.4807/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266275 CMS
Supernus Pharmaceuticals, Inc. $124.9907/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266235 CMS
Supernus Pharmaceuticals, Inc. $159.6707/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266239 CMS
Supernus Pharmaceuticals, Inc. $180.0007/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266243 CMS
Supernus Pharmaceuticals, Inc. $21.8007/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266247 CMS
Supernus Pharmaceuticals, Inc. $5,500.0007/27/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266251 CMS
Supernus Pharmaceuticals, Inc. $335.1007/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266255 CMS
Supernus Pharmaceuticals, Inc. $495.0007/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053266259 CMS
Alkermes, Inc. $214.6807/26/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022841803 CMS
Alkermes, Inc. $166.0807/26/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022841805 CMS
ITI, Inc. $5,400.0007/26/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040568431 CMS
ITI, Inc. $999.8007/26/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040568437 CMS
ITI, Inc. $298.2007/26/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040568447 CMS
ITI, Inc. $83.7607/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040568453 CMS
Otsuka America Pharmaceutical, Inc. $2,246.0007/26/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014429187 CMS
Otsuka America Pharmaceutical, Inc. $87.7807/26/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014429197 CMS
Otsuka America Pharmaceutical, Inc. $50.0007/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014429207 CMS
ITI, Inc. $5,400.0007/25/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040568405 CMS
ITI, Inc. $652.6007/25/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040568415 CMS
ITI, Inc. $129.7707/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040568421 CMS
BioXcel Therapeutics, Inc. $35.0007/21/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057514067 CMS
Alkermes, Inc. $503.3407/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022841795 CMS
Alkermes, Inc. $720.3907/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022841797 CMS
Alkermes, Inc. $115.8907/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022841799 CMS
Alkermes, Inc. $14.4407/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022841801 CMS
Teva Pharmaceuticals USA, Inc. $3,930.0007/20/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056653899 CMS
BioXcel Therapeutics, Inc. $248.9007/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057514055 CMS
BioXcel Therapeutics, Inc. $182.6807/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057514059 CMS
BioXcel Therapeutics, Inc. $192.0607/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057514063 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $491,998.83 649
PY2020 $199,877.71 199
PY2021 $356,603.07 319
PY2022 $515,616.09 541
PY2023 $598,886.86 656
PY2024 $629,695.30 658
PY2025 $817,141.37 849

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $109,254.00 33
PY2024 Principal investigator $36,449.18 13
PY2023 Principal investigator $70,537.96 12
PY2022 Recipient $1,995.00 2
PY2022 Principal investigator $33,721.06 9
PY2021 Recipient $10,519.00 9
PY2021 Principal investigator $60,144.00 10
PY2020 Recipient $9,306.00 2
PY2020 Principal investigator $45,937.24 5
PY2019 Recipient $2,696.88 13
PY2019 Principal investigator $94,234.92 60

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

33 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,739.00 11/21/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-321 No dispute reported 06/30/2026 1242366971
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,805.00 11/21/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-321 No dispute reported 06/30/2026 1242366973
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $838.00 10/02/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-321 No dispute reported 06/30/2026 1242360392
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,653.00 10/02/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-321 No dispute reported 06/30/2026 1242360394
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,046.00 10/02/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-321 No dispute reported 06/30/2026 1242360396
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,805.00 10/02/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-321 No dispute reported 06/30/2026 1242360398
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,782.00 10/02/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-321 No dispute reported 06/30/2026 1242360400
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $132.00 10/02/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-321 No dispute reported 06/30/2026 1242360402
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $53.00 10/02/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-321 No dispute reported 06/30/2026 1242360404
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $119.00 10/02/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-321 No dispute reported 06/30/2026 1242360406
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12,500.00 08/25/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-321 No dispute reported 06/30/2026 1242357704
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,907.00 08/14/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-321 No dispute reported 06/30/2026 1242357036
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4,046.00 08/14/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-321 No dispute reported 06/30/2026 1242357038
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,421.00 08/14/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-321 No dispute reported 06/30/2026 1242357040
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $119.00 08/04/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-421 No dispute reported 06/30/2026 1242355788
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,214.00 08/04/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-421 No dispute reported 06/30/2026 1242355790
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,214.00 08/04/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-421 No dispute reported 06/30/2026 1242355792
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5,272.00 08/04/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-421 No dispute reported 06/30/2026 1242355794
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,782.00 08/04/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-421 No dispute reported 06/30/2026 1242355796
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $53.00 08/04/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-421 No dispute reported 06/30/2026 1242355798
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5,696.00 07/07/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-421 No dispute reported 06/30/2026 1242352708
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5,696.00 07/07/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-421 No dispute reported 06/30/2026 1242352710
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $67.00 07/07/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-421 No dispute reported 06/30/2026 1242352712
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $67.00 07/07/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-421 No dispute reported 06/30/2026 1242352714
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $67.00 07/07/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-421 No dispute reported 06/30/2026 1242352716
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5,243.00 07/07/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-421 No dispute reported 06/30/2026 1242352718
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,214.00 07/07/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-421 No dispute reported 06/30/2026 1242352720
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,214.00 07/07/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-421 No dispute reported 06/30/2026 1242352722
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $3,848.00 07/07/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-421 No dispute reported 06/30/2026 1242352724
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $819.00 05/14/2025 Non-covered Recipient Entity
Neurobehavioral Medicine Group, Clinical Trials Division
TV50717-CNS-40223 No dispute reported 06/30/2026 1244052661
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $1,898.00 05/02/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-602 No dispute reported 06/30/2026 1242345691
Principal investigator 1 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15,500.00 05/02/2025 Non-covered Recipient Entity
NEUROBEHAVIORAL MEDICINE GROUP CLINICAL TRIALS DIVISION
ITI-007-602 No dispute reported 06/30/2026 1242345693
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $425.00 02/12/2025 Non-covered Recipient Entity
Neurobehavioral Medicine Group, Clinical Trials Division
TV50717-CNS-40223 No dispute reported 06/30/2026 1244052659